Whiz Laboratories (India) Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
as on 01-07-2024
- Paid Up Capital ₹ 0.95 M
as on 01-07-2024
- Company Age 24 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 8.95 M
as on 01-07-2024
- Satisfied Charges ₹ 2.03 M
as on 01-07-2024
- Revenue 5.28%
(FY 2021)
- Profit 35.88%
(FY 2021)
- Ebitda 13.71%
(FY 2021)
- Net Worth 21.23%
(FY 2021)
- Total Assets 21.63%
(FY 2021)
About Whiz Laboratories (India)
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 0.95 M.
The company currently has active open charges totaling ₹8.95 M. The company has closed loans amounting to ₹2.03 M, as per Ministry of Corporate Affairs (MCA) records.
Amarjit Singh and Khushwant Singh serve as directors at the Company.
- CIN/LLPIN
U51397PB2000PTC023326
- Company No.
023326
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
31 Jan 2000
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chandigarh
Industry
Company Details
- Location
Ludhiana, Punjab, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Whiz Laboratories (India) Private Limited offer?
Whiz Laboratories (India) Private Limited offers a wide range of products and services, including Cardiovascular Drugs & Medication, Kidney Drugs, Common Disease Medicines, Antihistamines, Pharmaceutical Medicine, Allopathic Cough Syrup, Brain & Nervous System Drugs, Antidepressant & Anti Anxiety Medicines, Blood Pressure Medicine, Nutraceuticals & Dietary Supplements.
Who are the key members and board of directors at Whiz Laboratories (India)?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Amarjit Singh  | Director | 31-Jan-2000 | Current |
| Khushwant Singh | Director | 13-Oct-2021 | Current |
Financial Performance of Whiz Laboratories (India).
Whiz Laboratories (India) Private Limited, for the financial year ended 2021, experienced modest growth in revenue, with a 5.28% increase. The company also saw a substantial improvement in profitability, with a 35.88% increase in profit. The company's net worth Soared by an impressive increase of 21.23%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Whiz Laboratories (India)?
Unlock access to Whiz Laboratories (India)'s control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 31 Mar 2023 | ₹0.90 M | Open |
Others Creation Date: 22 Jun 2020 | ₹1.05 M | Open |
Others Creation Date: 06 May 2014 | ₹7.00 M | Open |
How Many Employees Work at Whiz Laboratories (India)?
Unlock and access historical data on people associated with Whiz Laboratories (India), such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Whiz Laboratories (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Whiz Laboratories (India)'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
